Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART[S]

Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART[S]

The capacity of HDL to remove cholesterol from macrophages is inversely associated with the severity of angiographic coronary artery disease. The effect of human immunodeficiency virus (HIV) infection or its treatment on the ability of HDL particles to stimulate cholesterol efflux from human macroph...

Full description

Bibliographic Details
Main Authors:	Petra El Khoury, Mathilde Ghislain, Elise F. Villard, Wilfried Le Goff, Caroline Lascoux-Combe, Patrick Yeni, Laurence Meyer, Corinne Vigouroux, Cécile Goujard, Maryse Guerin
Format:	Article
Language:	English
Published:	Elsevier 2015-03-01
Series:	Journal of Lipid Research
Subjects:	high density lipoprotein function macrophage cholesterol efflux reverse cholesterol transport antiretroviral therapy human immunodeficiency virus highly active antiretroviral therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520355978

Similar Items

Determinants of long term survival of patients initiated on HAART at the AIDS support organization, Uganda
by: Awor, Anna Colletar
Published: (2017)

Differential rate of cholesterol efflux from the apical and basolateral membranes of MDCK cells
by: A.T. Remaley, et al.
Published: (1998-06-01)

Dental caries status of children receiving Highly active antiretroviral therapy (HAART) - A multicentric cross-sectional study in Tamil Nadu, India
by: G Shanmugavadivel, et al.
Published: (2020-01-01)

The prevalence of established factors associated with adherence to Highly Active Antiretroviral Therapy (HAART) in non-adhering patients at the ARV clinic of Madzikane KaZulu Memorial Hospital
by: Anizoba, O. O.
Published: (2015)

Prevalence of HIV-related opportunistic diseases amongst HAART patients at the Federal Medical Centre in Owerri, Nigeria
by: Onyebuchi, Iroezindu Michael
Published: (2016)

An analysis of clinical signs and symptoms which best predict the need for HAART initiation in HIV infected South African women
by: Horumpende, Pius Gerald
Published: (2010)

Reduced Reverse Cholesterol Transport Efficacy in Healthy Men with Undesirable Postprandial Triglyceride Response
by: Alexandre Motte Motte, et al.
Published: (2020-05-01)

The impact of in-utero highly active antiretroviral therapy (HAART) exposure on infant outcomes
by: Van der Merwe, Karin Joan
Published: (2011)

Clinical, demographic and laboratory parameters at HAART initiation associated with decreased post-HAART survival in a U.S. military prospective HIV cohort
by: Lifson Alan R, et al.
Published: (2012-02-01)

USF1 deficiency alleviates inflammation, enhances cholesterol efflux and prevents cholesterol accumulation in macrophages
by: Maija Ruuth, et al.
Published: (2018-12-01)

An adherence trilogy is essential for long-term HAART success
by: Garcia Rosa, et al.
Published: (2003-01-01)

An adherence trilogy is essential for long-term HAART success
by: Rosa Garcia, et al.

Cholesterol efflux capacity, HDL cholesterol, and risk of coronary heart disease: a nested case-control study in men
by: Leah E. Cahill, et al.
Published: (2019-08-01)

Truncation mutations in ABCA1 suppress normal upregulation of full-length ABCA1 by 9-cis-retinoic acid and 22-R-hydroxycholesterol
by: Cheryl L. Wellington, et al.
Published: (2002-11-01)

Lysosomal cholesterol derived from mildly oxidized low density lipoprotein is resistant to efflux
by: Patricia G. Yancey, et al.
Published: (2001-03-01)

High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
by: Maria Pia Adorni, et al.
Published: (2021-03-01)

Determinants of discordant immune response in a cohort of human immunodeficiency virus-infected patients initiating antiretroviral therapy
by: Abdullahi Umar, et al.
Published: (2020-01-01)

Craniofacial morphology of HIV-infected adolescents undergoing highly active antiretroviral therapy (HAART): An original research
by: M Neeraja, et al.
Published: (2020-01-01)

Cellular cholesterol efflux mediated by HDL isolated from subjects with low HDL levels and coronary artery disease
by: Luciana Uint, et al.
Published: (2003-07-01)

The burden of metabolic diseases amongst HIV positive patients on HAART attending the Johannesburg Hospital
by: Julius, Henry Patrick
Published: (2010)

Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux
by: Carlos L.J. Vrins, et al.
Published: (2009-10-01)

Prevalence and predictors of immunologic failure among HIV patients on HAART in southern Ethiopia
by: Kesetebirhan Delele Yirdaw
Published: (2015)

Prevalence and predictors of immunologic failure among HIV patients on HAART in southern Ethiopia
by: Kesetebirhan Delele Yirdaw
Published: (2015)

Comportamiento de la resistencia a drogas antirretrovirales en una consulta externa de La Habana durante el año 2012
by: Héctor Manuel Díaz Torres, et al.

HIV-specific CD8+ T cell responses in infected infacts enrolled on a study of early highly active antiretroviral treatment (HAART) and supervised treatment interruption (STI).
by: Thobakgale, Christina Fanesa.
Published: (2012)

Cell cholesterol efflux: integration of old and new observations provides new insights
by: George H. Rothblat, et al.
Published: (1999-05-01)

Walnut oil increases cholesterol efflux through inhibition of stearoyl CoA desaturase 1 in THP-1 macrophage-derived foam cells
by: Gillies Peter J, et al.
Published: (2011-08-01)

The relationship between lower limb muscle strength and lower limb function in hiv positive patients on highly active antiretroviral therapy
by: Mhariwa, Peter, Clever.
Published: (2017)

A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis
by: Binbin Xie, et al.
Published: (2021-02-01)

Prevalence of depressive symptoms amongst highly active antiretroviral therapy (HAART) patients in AIDSRelief Uganda
by: Constance Shumba, et al.
Published: (2013-11-01)

Factors affecting high-density lipoprotein cholesterol in HIV-infected patients on nevirapine-based antiretroviral therapy
by: C Padmapriyadarsini, et al.
Published: (2017-01-01)

Comparison of the effectiveness of initial combined antiretroviral therapy with nelfinavir or efavirenz at a university-based outpatient service in Brazil
by: T. Vanni, et al.
Published: (2007-07-01)

Association of cholesteryl ester transfer protein with HDL particles reduces its proteolytic inactivation by mast cell chymase
by: Miriam Lee-Rueckert, et al.
Published: (2008-02-01)

Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia[S]
by: Zélie Julia, et al.
Published: (2010-11-01)

Carvedilol Ameliorates Experimental Atherosclerosis by Regulating Cholesterol Efflux and Exosome Functions
by: Sy-Jou Chen, et al.
Published: (2019-10-01)

Involvement of caveolin-1 in cholesterol enrichment of high density lipoprotein during its assembly by apolipoprotein and THP-1 cells
by: Reijiro Arakawa, et al.
Published: (2000-12-01)

Cholesteryl ester flux from HDL to VLDL-1 is preferentially enhanced in type IIB hyperlipidemia in the postprandial state
by: Maryse Guerin, et al.
Published: (2002-10-01)

Erythrodiol, an Olive Oil Constituent, Increases the Half-Life of ABCA1 and Enhances Cholesterol Efflux from THP-1-Derived Macrophages
by: Limei Wang, et al.
Published: (2017-06-01)

The Dietary Constituent Falcarindiol Promotes Cholesterol Efflux from THP-1 Macrophages by Increasing ABCA1 Gene Transcription and Protein Stability
by: Limei Wang, et al.
Published: (2017-09-01)

Zymosan-mediated inflammation impairs in vivo reverse cholesterol transport[S]
by: Priya Malik, et al.
Published: (2011-05-01)